AYTU earnings: a negative outcome, -5.9%

On May 16, 2022, AYTU BIOPHARMA, INC reached its earnings. The result was a negative outcome, and the stock moved -5.9% in the window around the event. It had already run -44.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.